The trial demonstrated a significant reduction of 25% in the primary composite outcome of cardiovascular death and first HFH (19.4% versus 24.7% [HR 0.75
Another approved use for Victoza is to reduce the risk of major cardiovascular disease, like heart attack or stroke, in adults with type 2 diabetes with known heart disease
Savings based on standard monthly self-pay price
It also leads to the production of more free radicals (O 2 , ONOO , OH, and H 2 O 2 ) (Erejuwa, 2012), ROS production (Wu et al., 2018), and ultimately decrease glucose homeostasis and insulin sensitivity in the liver (Yang et al., 2010)
The picture that emerges is consistent across large trials and long follow-ups
Dilokthornsakul, W., Dhippayom, T., & Dilokthornsakul, P